Animal Researchfont-size: 18pt;">Magnesium may alleviate depression, anxiety, and have other potential nootropic benefits such as improved memory.
Magnesium is an abundant mineral required for optimal health. Magnesium has been suggested to have nootropic benefits through:
- Supporting brain biochemistry. Magnesium helps the brain’s neurons function properly by regulating neurotransmitters and other cognitive mechanisms.
- Supporting the stress response. Magnesium helps the body cope with stress, which is a major contributor to mental disorders.
Magnesium is an essential mineral with a wide variety of functions. It helps produce energy, make important biomolecules such as DNA, RNA, aids muscle & nerve function, regulate blood pressure, and much more. In addition, magnesium is known to play an important role in brain function by supporting optimal biochemistry.
Although most people get enough magnesium from their diet, insufficient (but not deficient) magnesium intake is estimated to affect some 48% of Americans (2005-2006 data).1 Because of this, supplementing with magnesium can have a wide range of health benefits. In fact, magnesium is one of the most popular supplement products, taken for everything from high blood pressure and blood sugar control to migraines and stress.
In addition, research reveals that insufficient magnesium levels are involved in depression, anxiety, panic disorders, and other mental illnesses. As such, the use of magnesium as a nootropic has been growing.
Foods High in Magnesium
|Food||Serving Size||Amount per serving (mg)|
|Cereal (all bran)||½ cup||112|
|Brown rice (cooked)||1 cup||86|
There is some evidence to support magnesium’s nootropic uses. Although there is a lack of definitive, high-quality studies, there is enough evidence for researchers to suggest that it may help with depression and anxiety-related disorders. 9 10
In addition, magnesium L-threonate is quickly becoming the most popular form of Mg for nootropic uses thanks to early animal evidence showing benefits such as enhanced memory, learning, and protection against Alzheimer’s.
Animal studies highlight the link between magnesium levels and mental conditions such as anxiety and depression. Specific findings indicate that:
- Hypomagnesemia (magnesium deficiency) can cause or increase anxiety in rodents 12 13
- Magnesium supplementation appears to reduce anxiety and depression in mice 14
- A novel form of Mg called magnesium L-threonate may be able to protect against Alzheimer’s and improve learning and memory in rats 15 16
Human Research>Magnesium supplementation may alleviate anxiety, depression, bipolar disorder, and related cognitive symptoms. However, these benefits only appear in cases where suboptimal magnesium levels are the underlying cause.
This study describes several case reports of people who showed fast recovery from depression following magnesium supplementation. In each case magnesium (125-300 mg glycinate or taurinate) was given to the person with depression, resulting in recovery after less than 7 days of supplementation.
- The researchers concluded that “The possibility that magnesium deficiency is the cause of most major depression and related mental health problems including IQ loss and addiction is enormously important to public health.” 17
This pilot study looked at the benefits of a form of magnesium called Magnesiocard (magnesium L-aspartate hydrochloride trihydrate) in the treatment of bipolar disorder. Nine patients were given a magnesium preparation daily for up to 32 weeks, resulting in improvement in half of the patients.
- The researchers concluded that “The possibility that Magnesiocard could replace or improve the efficacy of lithium as a preventive treatment of manic-depressive illness merits further clinical investigation.” 18
This study examined the magnesium and calcium levels in the cerebrospinal fluid (CSF) of people with depression, schizophrenia, and adjustment disorder. A total of 41 patients were compared to 15 healthy individuals. The study found that magnesium levels were significantly lower in people with depression and adjustment disorder, and particularly in people who attempted suicide.
- The researchers concluded that “Both variables seemed to be primarily related to recorded suicide attempts, but decreased magnesium was not limited to violent cases.” 19
This randomized, double-blind, placebo-controlled study looked at the benefits of magnesium for reducing premenstrual syndrome (PMS) symptoms on women. PMS is a disorder that can reduce the body’s magnesium levels and includes anxiety, depression, mood swings, stress, and other cognitive symptoms. A total of 32 women were given placebo or magnesium (360 mg) for 2 months, and then magnesium only for another 2 months. The supplementation improved mood-related symptoms of PMS such as anxiety, depression, and tension.
- The researchers concluded that “These data indicate that Mg supplementation could represent an effective treatment of premenstrual symptoms related to mood changes.” 20
This randomized, double-blind, placebo-controlled, crossover study examined the effects of magnesium plus vitamin B6 on premenstrual syndrome-related anxiety. A total of 44 women were given placebo, magnesium( 200 mg), vitamin B6 (50 mg), or both for one whole menstrual cycle, and repeated the supplementation 3 more times so that all women tried every treatment. Only the magnesium plus B6 group showed significant reduction of anxiety-related premenstrual symptoms, such as tension, mood swings, irritability, and anxiety.
- The researchers concluded that “A small synergistic effect of a daily dietary supplementation with a combination of Mg + vitamin B6 in the reduction of mild premenstrual anxiety-related symptoms was demonstrated during treatment of 44 women for one menstrual cycle.” 21
This randomized, placebo-controlled, double-blind study examined the effects of magnesium on anxiety. A total of 147 university students were given placebo or magnesium (300 mg) daily for 5 days before final exams to test its effects on test anxiety. There was no difference in anxiety between the two groups.
- The researchers concluded that “The level of self-reported anxiety before final exams did not differ between the placebo and Mg++ groups (p= 0.69).” 22
Supplements in Review Recommendation>
We recommend trying magnesium as a nootropic. Although we’d like to see more high-quality evidence before a conclusive recommendation, the existing studies do point to reduction of stress, anxiety, and related issues. As such, we recommend trying magnesium as a safe, natural nootropic.
Start with 200 mg magnesium L-threonate. We recommend taking 200-1000 mg daily dosages of magnesium L-threonate, as this is the only form of Mg that appears to have the full spectrum of nootropic benefits.
- Rosanoff A et al. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev. 2012 Mar;70(3):153-64. ↩
- Cernak I et al. Alterations in magnesium and oxidative status during chronic emotional stress. Magnes Res. 2000 Mar;13(1):29-36. ↩
- Coan EJ and Collingridge GL. Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci Lett. 1985 Jan 7;53(1):21-6. ↩
- Poleszak E. Benzodiazepine/GABA(A) receptors are involved in magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep. 2008 Jul-Aug;60(4):483-9. ↩
- Niswender CM and Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295-322. ↩
- Murck H and Steiger A. Mg2+ reduces ACTH secretion and enhances spindle power without changing delta power during sleep in men — possible therapeutic implications. Psychopharmacology (Berl). 1998 Jun;137(3):247-52. ↩
- Held K et al. Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry. 2002 Jul;35(4):135-43. ↩
- Nechifor M. Magnesium in major depression. Magnes Res. 2009 Sep;22(3):163S-166S. ↩
- Neil Bernard Boyle et al. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress—A Systematic Review. Nutrients. 2017 May; 9(5): 429. ↩
- Serefko A et al. Magnesium in depression. Pharmacol Rep. 2013;65(3):547-54. ↩
- George A. Eby et al. Magnesium and major depression. Adelaide (AU): University of Adelaide Press; 2011. ↩
- Sartori SB et al. Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology. 2012 Jan;62(1):304-12. ↩
- Pyndt Jørgensen B et al. Dietary magnesium deficiency affects gut microbiota and anxiety-like behaviour in C57BL/6N mice. Acta Neuropsychiatr. 2015 Oct;27(5):307-11. ↩
- Poleszak E et al. Antidepressant- and anxiolytic-like activity of magnesium in mice. Pharmacol Biochem Behav. 2004 May;78(1):7-12. ↩
- Slutsky I et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010 Jan 28;65(2):165-77. ↩
- Wei Li et al. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer’s disease mouse model. Molecular Brain 2014 7:65. ↩
- Eby GA and Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses. 2006;67(2):362-70. ↩
- Chouinard G et al. A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14(2):171-80. ↩
- Banki CM et al. Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry. 1985 Feb;20(2):163-71. ↩
- Facchinetti F et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991 Aug;78(2):177-81. ↩
- De Souza MC et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000 Mar;9(2):131-9. ↩
- Mathew H. Gendle and Krysten P. O’Hara. Oral Magnesium Supplementation and Test Anxiety in University Undergraduates. Journal of Articles in Support of the Null Hypothesis Vol. 11, No. 2, 2015. 1539-8714. ↩
- Hashizume N and Mori M. An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med. 1990 Jul-Aug;29(4):368-72. ↩
- Walker AF et al. Mg citrate more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003 Sep; 16(3): 183-91. ↩